Aliases & Classifications for Impetigo

About this section

Aliases & Descriptions for Impetigo:

Name: Impetigo 11 38 2 39 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:8504
ICD1030 L01, L01.0, L01.00
ICD9CM32 684
MeSH39 D007169
NCIt45 C99088

Summaries for Impetigo

About this section
MedlinePlus:38 Impetigo is a skin infection caused by bacteria. it is usually caused by staphylococcal (staph) bacteria, but it can also be caused by streptococcal (strep) bacteria. it is most common in children between the ages of two and six. it usually starts when bacteria get into a break in the skin, such as a cut, scratch, or insect bite. symptoms start with red or pimple-like sores surrounded by red skin. these sores can be anywhere, but usually they occur on your face, arms and legs. the sores fill with pus, then break open after a few days and form a thick crust. they are often itchy, but scratching them can spread the sores. impetigo can spread by contact with sores or nasal discharge from an infected person. you can treat impetigo with antibiotics. nih: national institute of allergy and infectious diseases

MalaCards based summary: Impetigo is related to bullous impetigo and impetigo herpetiformis, and has symptoms including exanthema, fever and pruritus. An important gene associated with Impetigo is DSG1 (Desmoglein 1), and among its related pathways are Lung fibrosis and Transcription_Role of VDR in regulation of genes involved in osteoporosis. Affiliated tissues include skin, eye and neutrophil.

Disease Ontology:11 A pyoderma consisting of three forms of skin lesions having either a thick, adherent, recurrent, dirty yellow crust with an erythematous margin (common or superficial impetigo) or lessions which are superficial, thin-walled, and bullous as found in bullous impetigo. The lesions in bullous (staphylococcal) impetigo, which are always caused by S aureus, are superficial, thin-walled, and bullous.

CDC:2 Group A Streptococcus (group A strep) is a bacterium that can cause many different infections, including strep throat, scarlet fever, impetigo, and others. The bacteria live in the nose and throat. When someone who is infected coughs or sneezes, the bacteria travel in small droplets of water called respiratory droplets. One of the ways you can get sick is if you breathe in those droplets or if you touch something that has the droplets on it and then touch your mouth, nose, or eyes.

Wikipedia:71 Impetigo is a bacterial infection that involves the superficial skin. The most common presentation is... more...

Related Diseases for Impetigo

About this section

Diseases related to Impetigo via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 103)
idRelated DiseaseScoreTop Affiliating Genes
1bullous impetigo12.3
2impetigo herpetiformis12.3
3pyoderma11.3
4ecthyma11.1
5prolidase deficiency10.8
6acute proliferative glomerulonephritis10.8
7necrotizing fasciitis10.8
8papilledema10.2IL36RN, IL6
9herpes zoster10.2DSG1, IL36RN
10mesenchymal cell neoplasm10.2CALCA, IL6
11hemangioma of orbit10.2ELANE, PI3
12brucella suis brucellosis10.2ELANE, PI3
13nodular prostate10.1CALCA, IL6
14radial hypoplasia, triphalangeal thumbs and hypospadias10.1ELANE, IL36RN
15central nervous system lymphoma10.1CALCA, IL6
16cholera10.1ELANE, IL6
17dermatitis10.1
18hirschsprung disease 110.1CALCA, EDNRB
19pancreatic serous cystadenoma10.1ELANE, HSF4
20hemopericardium10.1CALCA, EDNRB
21alcoholic hepatitis10.1ELANE, IL6
22breast apocrine carcinoma in situ10.1IL6, PI3
23pemphigus10.1
24atelosteogenesis ii10.0DSG1, ELANE, PI3
25radial defect robin sequence10.0ELANE, IL36RN, PI3
26pulmonary embolism and infarction10.0ELANE, IL36RN, PI3
27glomerulonephritis10.0
28scabies10.0
29thymic neuroendocrine carcinoma10.0IL6, MYOM2
30acute allergic sanguinous otitis media10.0IL6, MYOM2
31generalized atherosclerosis10.0IL6, MYOM2
32retinitis pigmentosa 5110.0ELANE, IL6
33dysbaric osteonecrosis10.0CALCA, IL6
34bipolar i disorder10.0IL6, MYOM2
35dextrocardia10.0IL6, MYOM2
36adnp syndrome10.0ELANE, IL6, PI3
37stomatitis10.0IL6, MYOM2
38subcorneal pustular dermatosis10.0ELANE, IL6, PI3
39childhood pleomorphic rhabdomyosarcoma10.0IL6, MYOM2
40tetanus10.0CALCA, ELANE, PI3
41childhood vagina botryoid rhabdomyosarcoma10.0CALCA, MYOM2
42atopic dermatitis10.0
43ethmoid sinus schneiderian papilloma10.0IL6, MYOM2
44dysentery10.0ELANE, HSF4, PI3
45infancy electroclinical syndrome10.0ELANE, IL6
46arteriosclerosis10.0ELANE, MYOM2
47psoriasis10.0
48esophagus carcinoma in situ10.0DSG1, EDNRB, HSF4
49tall cell variant papillary carcinoma9.9IL6, MYOM2
50pharyngitis9.9

Comorbidity relations with Impetigo via Phenotypic Disease Network (PDN):


Deficiency AnemiaHeart Disease
Acute Cystitis

Graphical network of the top 20 diseases related to Impetigo:



Diseases related to impetigo

Symptoms & Phenotypes for Impetigo

About this section

UMLS symptoms related to Impetigo:


exanthema, fever, pruritus

Drugs & Therapeutics for Impetigo

About this section

Drugs for Impetigo (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Fusidic AcidapprovedPhase 4, Phase 3126990-06-33000226
Synonyms:
(2Z)-2-[(17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene]-6-methylhept-5-enoic acid
(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
(2Z)-2-[(3alpha,4alpha,5alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid
16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
1qca
3.alpha.,11.alpha.,16.beta.-Trihydroxy-29-nor-8.alpha.,9.beta.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid 16-acetate
6990-06-3
AC1MHD21
AKOS005146257
C.A.S. 62,602
C06694
CHEBI:29013
CHEMBL374975
CID3000226
CPD0-1606
D04281
DB02703
Diethanolamine fusidate
F0756_SIAL
F0756_SIGMA
FUCIDIN
 
Fucidate
Fucidate Sodium
Fucidic acid
Fucidin Cream 2%
Fucidin acid
Fucithalmic
Fusidate
Fusidate sodium
Fusidic acid
Fusidic acid (USAN/INN)
Fusidine
LMPR0106040001
MLS001332649
MLS001332650
MLS002207094
NSC56192
Prestwick2_000390
Ramycin
SMR000857101
SQ 16,603
fusidic acid
nchembio.341-comp2
2
Permethrinapproved, investigationalPhase 43452645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
 
DB04930
Elimite Cream
FMC 35171
LS-58636
LS-58640
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
TL8003462
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
3
Ivermectinapproved, vet_approvedPhase 46170288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
4
AzithromycinapprovedPhase 434683905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
5Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
6Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 111226
7Antiparasitic AgentsPhase 42199
8
MentholapprovedPhase 2, Phase 326062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
9
Mupirocinapproved, investigational, vet_approvedPhase 2, Phase 3, Phase 16512650-69-0446596
Synonyms:
12650-69-0
1jzs
5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)
8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
AC1L9JV4
BIDD:GT0320
BRL 4910A
BRL-4910A
Bactoderm
Bactroban
Bactroban (TN)
Bactroban Nasal
C11758
C26H44O9
CHEBI:135271
CHEMBL719
CID446596
CPD000471888
Centany
Centany (TN)
 
D01076
DB00410
LS-177887
M7694_SIGMA
MLS001074711
MRC
MolPort-003-666-882
Mupirocin
Mupirocin (USP/INN)
Mupirocin, 14C-Labeled
Mupirocina
Mupirocina [Spanish]
Mupirocine
Mupirocine [French]
Mupirocinum
Mupirocinum [Latin]
NCGC00164554-03
Plasimine
Pseudomonic acid
Pseudomonic acid A
Pseudomonic acid a
SAM002589979
SMR000471888
UNII-D0GX863OA5
10
ZincapprovedPhase 322967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
11
Linezolidapproved, investigationalPhase 3116165800-03-3441401
Synonyms:
(S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
111GE017
165800-03-3
AC-16128
AC1L9B3M
BIDD:GT0404
C08146
C16H20FN3O4
CHEBI:126280
CHEMBL126
CID441401
CPD000466335
D00947
DB00601
DB08769
FT-0080803
HMS2051F08
HMS2089K06
HSDB 7478
LS-173594
Linezlid
Linezolid
Linezolid & VRC3375
Linezolid (JAN/USAN/INN)
Linezolid [USAN:INN]
Linezolide
 
Linezolidum
MLS000759444
MLS001424075
MolPort-003-986-503
N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
NDA 21-130 Zyvox (linezolid tablets)
NDA 21-131 Zyvox for injection (linezolid injection)
NDA 21-132 Zyvox oral suspension (linzolid oral suspension)
PNU 100766
PNU-100766
PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid
S1408_Selleck
SAM001246624
SMR000466335
TL8001272
U 100766
U-100766
ZINC02008866
ZLD
Zyvox
Zyvox (TN)
Zyvoxa
Zyvoxam
Zyvoxid
linezolid
12ExpectorantsPhase 2, Phase 3404
13AntipruriticsPhase 2, Phase 3841
14Dermatologic AgentsPhase 2, Phase 35806
15TerpinPhase 2, Phase 31
16Respiratory System AgentsPhase 2, Phase 34997
17Trace ElementsPhase 36001
18methicillinPhase 3162
19Antibiotics, AntitubercularPhase 3, Phase 27180
20MicronutrientsPhase 36001
21
Minocyclineapproved, investigationalPhase 223110118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline HCl
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
NCGC00178854-01
NSC 141993
NSC141993
Novo-Minocycline
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
22PapayaNutraceuticalPhase 116
23Vaccines6611

Interventional clinical trials:

(show all 27)
idNameStatusNCT IDPhase
1Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue InfectionCompletedNCT01126268Phase 4
2Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.CompletedNCT00555061Phase 4
3Azithromycin - Ivermectin Mass Drug Administration for Skin DiseaseActive, not recruitingNCT02775617Phase 4
4Fucidin® Cream in the Treatment of ImpetigoTerminatedNCT00986856Phase 4
5Citriodiol® and ImpetigoUnknown statusNCT01611909Phase 2, Phase 3
6Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo OintmentCompletedNCT00133848Phase 3
7Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoCompletedNCT02090764Phase 3
8Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoCompletedNCT01397461Phase 3
9Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in ImpetigoCompletedNCT01670032Phase 2, Phase 3
10Topical SB-275833 Ointment, 1% For The Treatment Of ImpetigoCompletedNCT00133874Phase 3
11Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompletedNCT00852540Phase 3
12Immunological and Clinical Responses to Zinc in Children With DiarrhoeaCompletedNCT00408356Phase 3
13Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo PatientsCompletedNCT01171326Phase 2
14The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or ImpetigoCompletedNCT00758862Phase 2
15A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in ImpetigoCompletedNCT01803035Phase 2
16Safety and Efficacy of Topical NVC-422 Gel in ImpetigoCompletedNCT01367314Phase 2
17Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)CompletedNCT00626795Phase 2
18A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin InfectionCompletedNCT01223222Phase 2
19Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoRecruitingNCT02902822Phase 2
20The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical TrialUnknown statusNCT01943136Phase 1
21EU PV for Retapamulin-PrescribingCompletedNCT01153828
22Surveillance of Streptococcal Infections in Children in IndiaCompletedNCT00342199
23Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern TerritoryCompletedNCT00884728
24The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
25United States Pharmacovigilence Retapamulin-PrescribingCompletedNCT01153880
26ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)CompletedNCT01445600
27Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in FijiNot yet recruitingNCT03177993

Search NIH Clinical Center for Impetigo


Cochrane evidence based reviews: impetigo

Genetic Tests for Impetigo

About this section

Anatomical Context for Impetigo

About this section

MalaCards organs/tissues related to Impetigo:

36
Skin, Eye, Neutrophil, Monocytes, T cells

Publications for Impetigo

About this section

Articles related to Impetigo:

(show top 50)    (show all 461)
idTitleAuthorsYear
1
Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains? (26895573)
2016
2
The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey. (27348119)
2016
3
Impetigo and scabies - Disease burden and modern treatment strategies. (27180311)
2016
4
A Case of Tinea Corporis due to Trichophyton tonsurans that Manifested as Impetigo. (27581776)
2016
5
Case of bullous impetigo with enormous bulla developing into staphylococcal scalded skin syndrome. (26603272)
2016
6
Staphylococcal bullous impetigo in a neonate. (27458596)
2016
7
Staphylococcus aureus penetrate the interkeratinocyte spaces created by skin-infiltrating neutrophils in a mouse model of impetigo. (27862501)
2016
8
Bullous impetigo and pregnancy: Case report and review of blistering conditions in pregnancy. (27617460)
2016
9
Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. (27736855)
2016
10
Protocol for the systematic review of the prevention, treatment and public health management of impetigo, scabies and fungal skin infections in resource-limited settings. (27659511)
2016
11
Bullous Impetigo Rapid Diagnostic and Therapeutic Quiz: A Model for Assessing Basic Dermatology Knowledge of Primary Care Providers. (27599660)
2016
12
Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. (27573023)
2016
13
Impetigo, Erysipelas and Cellulitis (26866211)
2016
14
An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case-control study. (27613059)
2016
15
Topical Minocycline Foam for the Treatment of Impetigo in Children: Results of a Randomized, Double-Blind, Phase 2 Study. (27741342)
2016
16
Crusted impetigo-like lesion on the face: a case of IgG/IgA pemphigus. (27879012)
2016
17
The Importance of Scabies Coinfection in the Treatment Considerations for Impetigo. (26599569)
2016
18
Impetigo contagiosa in a zosteriform pattern. (27333861)
2016
19
EB, or Not EB?" Neonatal Desquamative Impetigo in a Degloving Pattern. (26821848)
2016
20
Fabric-skin models to assess infection transfer for impetigo contagiosa in a kindergarten scenario. (25666081)
2015
21
Zosteriform impetigo: Wolf's isotopic response in a cutaneous immunocompromised district. (26336623)
2015
22
Tinea Faciei Caused by Trichophyton mentagrophytes (Molecular Type Arthroderma benhamiae ) Mimics Impetigo : A Case Report and Literature Review of Cases in Japan. (25855021)
2015
23
Allergic Contact Dermatitis to Benzoyl Peroxide Resembling Impetigo. (25782705)
2015
24
The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma. (26317533)
2015
25
Prevalence of scabies and impetigo worldwide: a systematic review. (26088526)
2015
26
Photodynamic Antibacterial Enhanced Effect Of Methylene Blue-Gold Nanoparticles Conjugate On Staph Aureus Isolated From Impetigo Lesions In Vitro Study. (25827622)
2015
27
Impetigo herpetiformis with IL36RN mutations in a Chinese patient: A founder haplotype of c.115+6T>C in East Asia. (26104679)
2015
28
Scabies and impetigo prevalence and risk factors in Fiji: a national survey. (25738499)
2015
29
Complete genome analysis of two new bacteriophages isolated from impetigo strains of Staphylococcus aureus. (26135320)
2015
30
Diffuse alveolar hemorrhage in a patient with acute poststreptococcal glomerulonephritis caused by impetigo. (25876581)
2015
31
Impetigo contagiosa with Nikolsky sign in adult patient of advanced malignant melanoma. (26173486)
2015
32
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway. (25229166)
2014
33
Case report of a rare dermatosis in pregnancy: Impetigo herpetiformis. (25303404)
2014
34
Impetigo - review. (24770507)
2014
35
Impetigo: treatment and management. (24683751)
2014
36
Impetigo contagiosa: an interesting and a very rare finding in a newborn. (24811108)
2014
37
Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. (25413895)
2014
38
IL36RN mutations underlie impetigo herpetiformis. (24717243)
2014
39
Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. (25340832)
2014
40
Impetigo. (25251010)
2014
41
Treatment of impetigo in resource-limited settings. (25172375)
2014
42
Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo. (25209523)
2014
43
A Retrospective Analysis of Skin Bacterial Colonisation, Susceptibility and Resistance in Atopic Dermatitis and Impetigo Patients. (25367860)
2014
44
Clinical inquiry: what is the best treatment for impetigo ? (25061625)
2014
45
Bullous impetigo. (24736928)
2014
46
Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. (25172376)
2014
47
Pediatric Burn Wound Impetigo After Grafting. (24823337)
2014
48
Extensive pustules in a neonate. Diagnosis: impetigo neonatorum. (25187389)
2014
49
Impetigo: diagnosis and treatment. (25250996)
2014
50
A Randomized, Double-blind, Comparative Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment 1% Versus Oral Linezolid in the Treatment of Secondarily Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus. (25396674)
2014

Variations for Impetigo

About this section

Expression for genes affiliated with Impetigo

About this section
Search GEO for disease gene expression data for Impetigo.

Pathways for genes affiliated with Impetigo

About this section

Pathways related to Impetigo according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6CALCA, IL6
29.6CALCA, IL6
39.5ELANE, IL6
49.4CALCA, EDNRB

GO Terms for genes affiliated with Impetigo

About this section

Cellular components related to Impetigo according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cornified envelopeGO:00015339.8DSG1, PI3

Biological processes related to Impetigo according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1monocyte chemotaxisGO:000254810.3CALCA, IL6
2negative regulation of bone resorptionGO:004577910.3CALCA, IL6
3antimicrobial humoral responseGO:001973010.2ELANE, PI3
4response to heatGO:000940810.2CALCA, IL6
5negative regulation of chemokine biosynthetic processGO:004507910.2ELANE, IL6
6positive regulation of smooth muscle cell proliferationGO:004866110.2ELANE, IL6
7regulation of blood pressureGO:000821710.0CALCA, EDNRB
8response to yeastGO:00018789.9ELANE, IL6
9response to painGO:00482659.8CALCA, EDNRB
10agingGO:00075689.6CALCA, EDNRB, IL6
11vasodilationGO:00423119.4CALCA, EDNRB
12response to lipopolysaccharideGO:00324969.4EDNRB, ELANE, IL6

Sources for Impetigo

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet